HA
TRML

HHLR Advisors’s Tourmaline Bio TRML Stock Holding History

HHLR Advisors’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-26,615
Closed -$1.2M – 67
2022
Q2 		$1.2M Sell
26,615
-43,265
-62% -$3.41M 0.03% 60
2022
Q1 		$6.88M Sell
69,880
-6,309
-8% -$590K 0.14% 39
2021
Q4 		$11.6M Hold
76,189
– – 0.18% 46
2021
Q3 		$10.3M Sell
76,189
-9,145
-11% -$1.25M 0.14% 60
2021
Q2 		$12.5M Buy
+85,334
New +$13.1M 0.13% 64

Other funds holding TRML

Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

HHLR Advisors's TRML Position: Q3 2022 in Review

HHLR Advisors sold out of Tourmaline Bio (TRML) in Q3 2022, closing a stake of 26,615 shares — an estimated $1.2M sold.

HHLR Advisors first reported a position in TRML in Q2 2021 and held it in 5 quarters. The position peaked at $12.5M in Q2 2021. 56 funds tracked by Wall St. Rank hold TRML as of Q3 2022.

  • HHLR Advisors reported no remaining Tourmaline Bio position as of Q3 2022 after selling out during the quarter.
  • HHLR Advisors sold 26,615 Tourmaline Bio shares in Q3 2022, an estimated $1.2M.
  • HHLR Advisors first reported a position in Tourmaline Bio in Q2 2021 and held it in 5 quarters.
  • HHLR Advisors's Tourmaline Bio position peaked at $12.5M in Q2 2021.
  • 56 funds tracked by Wall St. Rank held Tourmaline Bio as of Q3 2022.

Based on HHLR Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.